These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 29113604)

  • 1. Tau accumulation in two patients with frontotemporal lobe degeneration showing different types of aphasia using 18F-THK-5351 positron emission tomography: a case report.
    Takaya M; Ishii K; Hosokawa C; Saigoh K; Shirakawa O
    Int Psychogeriatr; 2018 May; 30(5):641-646. PubMed ID: 29113604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progression of logopenic aphasia to frontotemporal dementia in an amyloid β-negative and
    Takaya M; Ishii K; Kubota I; Shirakawa O
    Psychogeriatrics; 2019 Jul; 19(4):399-401. PubMed ID: 30712283
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical Evaluation of 18F-PI-2620 as a Potent PET Radiotracer Imaging Tau Protein in Alzheimer Disease and Other Neurodegenerative Diseases Compared With 18F-THK-5351.
    Oh M; Oh SJ; Lee SJ; Oh JS; Roh JH; Chung SJ; Lee JH; Lee CS; Kim JS
    Clin Nucl Med; 2020 Nov; 45(11):841-847. PubMed ID: 32910050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Kobayashi R; Hayashi H; Kawakatsu S; Ishiki A; Okamura N; Arai H; Otani K
    BMC Neurol; 2018 Aug; 18(1):109. PubMed ID: 30089453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of pathology in primary progressive language and speech disorders.
    Deramecourt V; Lebert F; Debachy B; Mackowiak-Cordoliani MA; Bombois S; Kerdraon O; Buée L; Maurage CA; Pasquier F
    Neurology; 2010 Jan; 74(1):42-9. PubMed ID: 19940270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
    Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
    J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flortaucipir tau PET imaging in semantic variant primary progressive aphasia.
    Makaretz SJ; Quimby M; Collins J; Makris N; McGinnis S; Schultz A; Vasdev N; Johnson KA; Dickerson BC
    J Neurol Neurosurg Psychiatry; 2018 Oct; 89(10):1024-1031. PubMed ID: 28986472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of Amyloid Imaging Positivity in Patients With Primary Progressive Aphasia.
    Santos-Santos MA; Rabinovici GD; Iaccarino L; Ayakta N; Tammewar G; Lobach I; Henry ML; Hubbard I; Mandelli ML; Spinelli E; Miller ZA; Pressman PS; O'Neil JP; Ghosh P; Lazaris A; Meyer M; Watson C; Yoon SJ; Rosen HJ; Grinberg L; Seeley WW; Miller BL; Jagust WJ; Gorno-Tempini ML
    JAMA Neurol; 2018 Mar; 75(3):342-352. PubMed ID: 29309493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of [
    Schaeverbeke J; Celen S; Cornelis J; Ronisz A; Serdons K; Van Laere K; Thal DR; Tousseyn T; Bormans G; Vandenberghe R
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1949-1960. PubMed ID: 31848674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct [
    Schaeverbeke J; Evenepoel C; Declercq L; Gabel S; Meersmans K; Bruffaerts R; Adamczuk K; Dries E; Van Bouwel K; Sieben A; Pijnenburg Y; Peeters R; Bormans G; Van Laere K; Koole M; Dupont P; Vandenberghe R
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2342-2357. PubMed ID: 29946950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [18F]-THK5351 PET Imaging in Patients With Semantic Variant Primary Progressive Aphasia.
    Lee H; Seo S; Lee SY; Jeong HJ; Woo SH; Lee KM; Lee YB; Park KH; Heo JH; Yoon CW; Kang JM; Cho J; Okamura N; Furumoto S; Yanai K; Na DL; Ido T; Villemagne VL; Noh Y
    Alzheimer Dis Assoc Disord; 2018; 32(1):62-69. PubMed ID: 29028649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.
    Leinonen V; Rauramaa T; Johansson J; Bottelbergs A; Tesseur I; van der Ark P; Pemberton D; Koivisto AM; Jääskeläinen JE; Hiltunen M; Herukka SK; Blennow K; Zetterberg H; Jokinen P; Rokka J; Helin S; Haaparanta-Solin M; Solin O; Okamura N; Kolb HC; Rinne JO
    J Alzheimers Dis; 2018; 64(1):171-179. PubMed ID: 29865068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting metabolic impairment in frontotemporal degeneration and early onset Alzheimer's disease.
    Ibach B; Poljansky S; Marienhagen J; Sommer M; Männer P; Hajak G
    Neuroimage; 2004 Oct; 23(2):739-43. PubMed ID: 15488423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [
    Blazhenets G; Soleimani-Meigooni DN; Thomas W; Mundada N; Brendel M; Vento S; VandeVrede L; Heuer HW; Ljubenkov P; Rojas JC; Chen MK; Amuiri AN; Miller Z; Gorno-Tempini ML; Miller BL; Rosen HJ; Litvan I; Grossman M; Boeve B; Pantelyat A; Tartaglia MC; Irwin DJ; Dickerson BC; Baker SL; Boxer AL; Rabinovici GD; La Joie R
    J Nucl Med; 2023 Dec; 64(12):1980-1989. PubMed ID: 37918868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-phase
    Kuo HC; Hsiao IT; Hsieh CJ; Huang CY; Huang KL; Wai YY; Chuang WL; Kung MP; Chu YC; Yen TC; Lin KJ; Huang CC
    J Formos Med Assoc; 2017 Dec; 116(12):964-972. PubMed ID: 28434708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicoradiological and neuropathological evaluation of primary progressive aphasia.
    Shir D; Corriveau-Lecavalier N; Bermudez Noguera C; Barnard L; Pham NTT; Botha H; Duffy JR; Clark HM; Utianski RL; Knopman DS; Petersen RC; Boeve BF; Murray ME; Nguyen AT; Reichard RR; Dickson DW; Day GS; Kremers WK; Graff-Radford NR; Jones DT; Machulda MM; Fields JA; Whitwell JL; Josephs KA; Graff-Radford J
    J Neurol Neurosurg Psychiatry; 2024 Aug; 95(9):812-821. PubMed ID: 38514176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical Evaluation of [(18)F]THK-5105 Enantiomers: Effects of Chirality on Its Effectiveness as a Tau Imaging Radiotracer.
    Tago T; Furumoto S; Okamura N; Harada R; Adachi H; Ishikawa Y; Yanai K; Iwata R; Kudo Y
    Mol Imaging Biol; 2016 Apr; 18(2):258-66. PubMed ID: 26194011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
    Okamura N; Furumoto S; Harada R; Tago T; Yoshikawa T; Fodero-Tavoletti M; Mulligan RS; Villemagne VL; Akatsu H; Yamamoto T; Arai H; Iwata R; Yanai K; Kudo Y
    J Nucl Med; 2013 Aug; 54(8):1420-7. PubMed ID: 23857514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal study of primary progressive aphasia in a patient with pathologically diagnosed Alzheimer's disease: a case report.
    Takaya M; Ishii K; Saigoh K; Shirakawa O
    J Med Case Rep; 2021 May; 15(1):272. PubMed ID: 34034805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau-PET imaging with [18F]AV-1451 in primary progressive apraxia of speech.
    Utianski RL; Whitwell JL; Schwarz CG; Senjem ML; Tosakulwong N; Duffy JR; Clark HM; Machulda MM; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Cortex; 2018 Feb; 99():358-374. PubMed ID: 29353121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.